Quantumzyme Corp. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD from Q3 2015 to 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
-
Summary
-
Quantumzyme Corp. quarterly/annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and growth rate from Q3 2015 to 2025.
- Quantumzyme Corp. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending April 30, 2025 was -$65.8K, a 2.98% decline year-over-year.
- Quantumzyme Corp. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2025 was -$199K, a 11.6% decline from 2024.
- Quantumzyme Corp. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2024 was -$179K.
- Quantumzyme Corp. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2018 was -$28.2K, a 27.1% increase from 2017.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Growth (%)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Annual (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Annual Growth (%)